Feb 27, 2022
The majority of people living with multiple sclerosis (MS) are initially diagnosed with relapsing-remitting MS, meaning they experience periods of acute symptoms, called relapses or exacerbations, that are generally followed by periods with minimal, or at least less...
Feb 27, 2022
Are you unsure whether your anxiety is normal or if it has escalated to unhealthy levels? Knowing the difference between healthy anxiety and a clinical anxiety disorder can help you sort out what kind of professional help you might need and which coping strategies are...
Feb 27, 2022
Tumefactive multiple sclerosis (MS), also known as Balo’s concentric sclerosis or Balo’s disease, is a rare form of MS with symptoms resembling those of a brain tumor. Less than 1 percent of all MS cases are diagnosed as tumefactive MS. Tumefactive MS typically...
Feb 27, 2022
The cause of multiple sclerosis (MS) is unknown. Scientists have proven that MS is autoimmune in origin. In other words, the damage in MS is caused by the body’s immune system attacking its own tissues, but scientists have not yet figured out why this process begins. ...
Feb 24, 2022
Synaptogenix announced plans to advance bryostatin-1, its lead candidate, into clinical trials for multiple sclerosis (MS), marking the third neurological disease the small molecule therapy is being developed to potentially treat. “Multiple sclerosis joins Alzheimer’s...
Feb 23, 2022
Optic neuritis (ON) is an inflammatory and demyelinating eye condition that causes eye pain and sudden vision loss. It is a common condition among people living with multiple sclerosis (MS), regardless of the type of MS they have. Nearly 50 percent of people with MS...
